Sanara MedTech annual meeting results: all proposals approved; board adopts triennial advisory vote on exec comp

Sanara MedTech Inc.

All nine director nominees elected, with each receiving >5M for votes (including Yon, Nixon, DeSutter).
Weaver and Tidwell ratified as auditor for FY2026: 6,696,035 for, 2,198 against.
Advisory say-on-pay approved: 5,280,546 for (98.9% of votes cast).
Frequency vote favors three years (4,296,133); board sets triennial advisory vote on exec comp, next vote in 2029.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Sanara MedTech Inc. shareholders approved Ratification of the appointment of Weaver and Tidwell, L.L.P. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-04 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

Proposal 2 : Ratification of the appointment of Weaver and Tidwell, L.L.P. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Sanara MedTech Inc. shareholders approved Advisory approval of the compensation of the Company’s named executive officers at the 2026-06-04 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

Proposal 3: Approval, on an advisory basis, of the compensation of the Company’s named executive officers.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Sanara MedTech Inc. shareholders approved Advisory vote on the frequency of future advisory votes on named executive officer compensation at the 2026-06-04 meeting.

Proposal: say on pay frequency
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

Proposal 4 : Approval, on an advisory basis, of the frequency of future advisory votes on named executive officer compensation.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Sanara MedTech Inc. shareholders approved Election of nine directors to serve for a one-year term until 2027 annual meeting at the 2026-06-04 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

Proposal 1 : Election of (i) Seth D. Yon, (ii) Ronald T. Nixon, (iii) Robert A. DeSutter, (iv) Roszell Mack III, (v) Eric D. Major, (vi) Keith G. Myers, (vii) Sara N. Ortwein, (viii) Ann Beal Salamone and (ix) Eric D. Tanzberger to the Board of Directors of the Company, each to serve for a one-year term until the annual meeting of shareholders to be held in 2027 and until his or her successor is elected and qualified.

View on SEC.gov

1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Sanara MedTech Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-027936

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.